DK0500659T3 - Monoklonale antistoffer. - Google Patents

Monoklonale antistoffer.

Info

Publication number
DK0500659T3
DK0500659T3 DK90916718.1T DK90916718T DK0500659T3 DK 0500659 T3 DK0500659 T3 DK 0500659T3 DK 90916718 T DK90916718 T DK 90916718T DK 0500659 T3 DK0500659 T3 DK 0500659T3
Authority
DK
Denmark
Prior art keywords
rhesus
antibody molecules
monoclonal antibodies
chimeric antibody
antibodies
Prior art date
Application number
DK90916718.1T
Other languages
English (en)
Inventor
Nevin Campbell Hughes-Jones
Original Assignee
Nat Blood Authority
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Blood Authority filed Critical Nat Blood Authority
Application granted granted Critical
Publication of DK0500659T3 publication Critical patent/DK0500659T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C07K16/464—Igs containing CDR-residues from one specie grafted between FR-residues from another
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK90916718.1T 1989-11-13 1990-11-13 Monoklonale antistoffer. DK0500659T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898925590A GB8925590D0 (en) 1989-11-13 1989-11-13 Monoclonal antibodies

Publications (1)

Publication Number Publication Date
DK0500659T3 true DK0500659T3 (da) 1997-07-14

Family

ID=10666204

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90916718.1T DK0500659T3 (da) 1989-11-13 1990-11-13 Monoklonale antistoffer.

Country Status (11)

Country Link
US (2) US5831063A (da)
EP (1) EP0500659B1 (da)
AT (1) ATE148168T1 (da)
AU (1) AU647054B2 (da)
CA (1) CA2068222C (da)
DE (1) DE69029808T2 (da)
DK (1) DK0500659T3 (da)
ES (1) ES2098274T3 (da)
GB (1) GB8925590D0 (da)
GR (1) GR3022847T3 (da)
WO (1) WO1991007492A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5495002A (en) * 1984-01-31 1996-02-27 Akzo N.V. Tumor associated monoclonal antibody 123AV16
GB9020282D0 (en) 1990-09-17 1990-10-31 Gorman Scott D Altered antibodies and their preparation
US6326488B1 (en) 1990-10-19 2001-12-04 Board Of Trustees Of University Of Illinois Gene and genetic elements associated with sensitivity to chemotherapeutic drugs
US6800738B1 (en) 1991-06-14 2004-10-05 Genentech, Inc. Method for making humanized antibodies
WO1994004679A1 (en) * 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
EP1400536A1 (en) 1991-06-14 2004-03-24 Genentech Inc. Method for making humanized antibodies
JP3502093B2 (ja) * 1991-07-15 2004-03-02 ザ・ウエルカム・ファウンデーション・リミテッド 抗体の製造
FR2724182B1 (fr) * 1994-09-02 1996-12-13 Pasteur Institut Obtention d'un anticorps monoclonal recombinant a partir d'un anticorps monoclonal humain anti-rhesus d, sa production en cellules d'insecte, et ses utilisations
KR100361449B1 (ko) 1996-06-24 2003-01-24 체트엘베 바이오플라스마 아게 리서스D항원들(RhesusDantigens)에특정적인항원결합구조들을형성할수있는폴리펩티드들,그것들을인코딩한DNA,그리고그것들의제조방법및용도
IL151499A0 (en) 2000-03-03 2003-04-10 Cambridge Antibody Tech Human antibodies against eotaxin and their use
US6946546B2 (en) 2000-03-06 2005-09-20 Cambridge Antibody Technology Limited Human antibodies against eotaxin
FR2807767B1 (fr) 2000-04-12 2005-01-14 Lab Francais Du Fractionnement Anticorps monoclonaux anti-d
SG141239A1 (en) * 2001-01-26 2008-04-28 Selexis Sa Matrix attachment regions and methods for use thereof
WO2003000908A1 (en) * 2001-06-21 2003-01-03 Ecole Polytechnique Federale De Lausanne A method for introducing a nucleic acid into a eukaryotic cell
US7658924B2 (en) * 2001-10-11 2010-02-09 Amgen Inc. Angiopoietin-2 specific binding agents
US7521053B2 (en) 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
GB0324368D0 (en) * 2003-10-17 2003-11-19 Univ Cambridge Tech Polypeptides including modified constant regions
JP5396653B2 (ja) 2003-10-24 2014-01-22 セレキス エスアー Ｍａｒ配列の多トランスフェクション手順による高効率の遺伝子導入および哺乳動物細胞における発現
ES2401536T3 (es) * 2007-11-13 2013-04-22 Evec Inc. Anticuerpos monoclonales que se unen a HGM-CSF y composiciones medicinales que los comprenden
JO2913B1 (en) 2008-02-20 2015-09-15 امجين إنك, Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) * 1986-03-27 1986-04-30 Winter G P Recombinant dna product
GB8610106D0 (en) * 1986-04-25 1986-05-29 Central Blood Lab Authority Human igm-producing heterohybridoma
AU622417B2 (en) * 1987-09-18 1992-04-09 National Blood Authority Human anti-rh(d) monoclonal antibodies
AU623345B2 (en) * 1987-09-18 1992-05-14 National Blood Authority Human anti-rh(d) monoclonal antibodies

Also Published As

Publication number Publication date
ATE148168T1 (de) 1997-02-15
WO1991007492A1 (en) 1991-05-30
US5831063A (en) 1998-11-03
GR3022847T3 (en) 1997-06-30
AU6721490A (en) 1991-06-13
ES2098274T3 (es) 1997-05-01
DE69029808T2 (de) 1997-07-10
EP0500659B1 (en) 1997-01-22
CA2068222A1 (en) 1991-05-14
EP0500659A1 (en) 1992-09-02
US5919910A (en) 1999-07-06
AU647054B2 (en) 1994-03-17
DE69029808D1 (de) 1997-03-06
CA2068222C (en) 1999-05-11
GB8925590D0 (en) 1990-01-04

Similar Documents

Publication Publication Date Title
ES2098274T3 (es) Anticuerpos monoclonales.
BR9507594B8 (pt) Anticorpo monoclonal com scfv humanizado, molécula de ácido nucleico recombinante e proteína recombinante.
WO2002020569A3 (en) Mammalian genes; related reagents and methods
CY1108545T1 (el) Πρωτεϊνες υπομοναδας υποδοχεα κυτοκινης θηλαστικου, σχετικα αντιδραστηρια και μεθοδοι
WO1998050433A3 (en) Human monoclonal antibodies to epidermal growth factor receptor
WO2003060080A3 (en) Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them
ATE137534T1 (de) Cdr-gepfropfte anti-cea-antikörper und ihre herstellung
ATE248605T1 (de) Für e-selectin und p-selectin spezifische kreuzreaktive monoklonale antikörper
DK0460076T3 (da) Genetisk manipulerede immunoglobuliner
ES2293973T3 (es) Anticuerpos anti-ccr2 humanizados y metodos de uso de los mismos.
ATE132197T1 (de) Monoklonale antikörper
ATE509955T1 (de) Humanisierte kollagen-antikörper und damit verbundene verfahren
WO2001090358A3 (en) Mammalian receptor proteins; related reagents and methods
EP1433792A8 (en) Human receptor proteins, related reagents and methods
ATE370235T1 (de) Rekombinantpeptide hergeleitet vom mc3 antikörper gegen ba46, verfahren zu deren verwendung und verfahren zur humanisierung von antikörperpeptiden
NO986088L (no) Polypeptider med evnen til Õ danne antigenbindende strukturer med spesifisitet for Rhesus D-antigener, DNA som koder for disse, fremgangsmÕter for fremstilling av disse og anvendelse av disse
WO2002074251A3 (en) Monoclonal antibody therapy for pancreas cancer
WO1999046379A3 (en) Human receptor proteins; related reagents and methods
NO985904L (no) TIE-2-reseptorligander (TIE-ligand-3, TIE-ligand-4), samt anvendelse derav
DK1181366T4 (da) Mammale receptorproteiner, beslægtede reagenser og fremgangsmåder
WO2001057219A3 (en) Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods
FR2560212B1 (fr) Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
EP0972054A4 (en) INCREASING IMMUNE RESPONSE USING TARGETED MOLECULES
WO2002000005A8 (en) Libraries displaying human antibody fragments with hybrid complementarity determining regions
DK0889907T3 (da) Monoklonale antistoffer, som binder humant væksthormon (hGH)